This single institution retrospective study compared outcomes for lobectomy and segmentectomy using propensity score matching. For 312 pts in each group, there was no difference in logoregional or overall recurrence rates. Operative mortality rates were similar for segmentectomy and lobectomy (1.2% vs 2.5%). 5-year surival rates were also similar
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Thoracic
July 1, 2014
This randomized trial of high risk patients with small clinial stage I cancers randomized pts to sublobar resection with or without adjuvant brachytherapy. The median follow-up for 222 pts was 4.4 years. 3 year survival was identical (71%) between the groups. There was no difference in time to local recurrence. Brachytherapy did not significantly
July 1, 2014
In this randomized trial involving195 pts from 30 centers, pts underwent chemoradiotherapy followed by surgery or surgery alone for stage I or II esophageal cancer. The median follow-up was 94 months. 80% of pts had clinical stage II disease. R0 resection rate and 3-year survival were similar between the groups. Induction therapy was associated w
June 30, 2014
Shanda Blackmon, Daniel Boffa, Farhood Farjah, and Gaetano Rocco discuss lung cancer screening at the 2014 STS Annual Meeting.
June 26, 2014
Joseph Shrager, Chief of the Stanford Division of Thoracic Surgery, discusses the process of establishing a lung cancer screening program.
June 26, 2014
Although lung cancer is common in the elderly population, little information specific to this population is available to inform healthcare practitioners. The EORTC, in collaboration with the International Society of Geriatric Oncology, released a concensus statement in 2010 on this topic. Since then a number of related studies have been published.
June 25, 2014
In this study presented by Dr. Joshua A. Roth recently at the ASCO meeting, they used a model to forecast the 5-year results of implementation of a screening program (as suggest the NLST, age older than 55 with at least 30 pack-years of smoking history) in comparison to no screening program.
June 25, 2014
Predictors of resectability on preoperative CT were evaluated in 133 pts undergoing resection for thymoma over a 13 year period in a single institution. 60% of pts were Masaoka stage I or II. 17% of pts had an incomplete resection. On multivariate analysis, pleural nodularity and the degree of abutment of adjacent vessels predicted incomplete rese
June 25, 2014
This single institution study evaluated prognostic factors in 262 pts undergoing thymectomy for thymic tumors over a 25-year period. The majority of tumors were Masaoka stage II and the most common histology was WHO type B. 15 year survival was 91%. Recurrence was related to Masaoka stage and tumor size.
June 24, 2014
Raja Flores, Professor and Chairman of the Mount Sinai School of Medicine Department of Thoracic Surgery, discusses the use of pleurectomy and decortication in the treatment of mesothelioma.